Package 63539-221-21

{"route": ["INTRACAVERNOUS"], "spl_id": "e742118b-48b5-4262-9efb-dbc4bd08aec8", "openfda": {"nui": ["N0000009059", "N0000175454", "N0000180189", "N0000000106", "M0017805", "N0000009911"], "unii": ["F5TD010360"], "rxcui": ["763470", "763472", "763473", "763474"], "spl_set_id": ["d8f85a7e-becb-4e15-9829-40e8f359140a"], "pharm_class_cs": ["Prostaglandins [CS]"], "pharm_class_pe": ["Genitourinary Arterial Vasodilation [PE]", "Venous Vasodilation [PE]"], "pharm_class_epc": ["Prostaglandin Analog [EPC]", "Prostaglandin E1 Agonist [EPC]"], "pharm_class_moa": ["Prostaglandin Receptor Agonists [MoA]"], "manufacturer_name": ["U.S. Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE in 1 CARTON (63539-221-21)  / .5 mL in 1 SYRINGE (63539-221-20)", "package_ndc": "63539-221-21", "marketing_start_date": "20140504"}], "brand_name": "Caverject Impulse", "product_id": "63539-221_e742118b-48b5-4262-9efb-dbc4bd08aec8", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Genitourinary Arterial Vasodilation [PE]", "Prostaglandin Analog [EPC]", "Prostaglandin E1 Agonist [EPC]", "Prostaglandin Receptor Agonists [MoA]", "Prostaglandins [CS]", "Venous Vasodilation [PE]"], "product_ndc": "63539-221", "generic_name": "Alprostadil", "labeler_name": "U.S. Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Caverject Impulse", "active_ingredients": [{"name": "ALPROSTADIL", "strength": "20 ug/.5mL"}], "application_number": "NDA021212", "marketing_category": "NDA", "marketing_start_date": "20140504", "listing_expiration_date": "20261231"}